Table 1. Patients’ demographics and clinicopathological features (N=30).
Characteristic |
Frequency |
||
---|---|---|---|
No. | % | ||
Age at diagnosis, years | |||
Median | 63.8 | ||
Range | 46-84 | ||
Male sex | 15 | 50% | |
Race/ethnicity | |||
Caucasians | 27 | 90% | |
African-American | 2 | 7%* | |
Not reported | 1 | 3%* | |
Type of cancer | |||
Pancreatic adenocarcinoma | 26 | 87%* | |
Cholangiocarcinoma | 3 | 10% | |
Ampulla of Vater | 1 | 3%* | |
Stage (TNM) | |||
I | 5 | 17%* | |
II | 20 | 67%* | |
III | 3 | 10% | |
IV | 2 | 7%* | |
Adjuvant treatment | 18 | 60% | |
Chemoradiotherapy | 12 | 40% | |
Chemotherapy alone | 6 | 20% | |
Untreated | 9 | 30% | |
Unknown | 3 | 10% |
*Percentages were rounded off